Related Articles
BIIB021, an Hsp90 inhibitor: A promising therapeutic strategy for blood malignancies (Review)
Preclinical antitumor activity of SST0116CL1: A novel heat shock protein 90 inhibitor
Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling
Hsp90 inhibitor as a sensitizer of cancer cells to different therapies (Review)
HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)